<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39354396</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Impact of SARS-CoV-2 viral load on restrictive spirometry patterns in mild COVID-19 recovered middle-aged individuals: a six-month prospective study.</ArticleTitle><Pagination><StartPage>1089</StartPage><MedlinePgn>1089</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1089</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09959-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long term respiratory complications of Corona Virus Disease-2019 (COVID-19) are of great concern. Many studies have reported altered respiratory patterns in COVID-19 recovered individuals and most of them were from severe to critically ill patients. The association of viral load at the time of infection with symptoms of long COVID-19 specifically on pulmonary functions after months of recovery is still not known. This study was aimed to assess the impact of SARS-CoV-2 viral load during mild-moderate COVID-19 disease on pulmonary functions in middle-aged population after 6-8 months of acute infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study included 300 (102 healthy controls and 198 COVID-19 recovered) individuals between age 30-60 of either gender. Mild-moderate COVID-19 recovered individuals were recruited between a period of 6-8 months post-acute infection. Spirometry was performed with MIR-Spirolab-III. The association of spirometry pattern was compared with SARS-CoV-2 viral loads during acute infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed up to 70% of the participants presented with either shortness of breath (11.5%), body aches (23.5%), recurrent cough (4.4%), recurrent respiratory infections (9.5%) and/or fatigue (33.3%) at follow up. In our study, 35.5% of COVID-19 recovered individuals had abnormal respiratory patterns (33.5% had restrictive and 2% had obstructive patterns). Viral load&#x2009;&#x2264;&#x2009;20 CT value was associated with restrictive respiratory patterns (p&#x2009;=&#x2009;0.004). No association was found between viral load and disease severity (p&#x2009;=&#x2009;0.23).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this study, we found one third of mild-moderate COVID-19 recovered individuals have restrictive respiratory patterns after 6-8 months of recovery. These findings had a strong association with SARS-CoV-2 viral loads during acute infection which has been reported for the first time in our study. Studying the relationship between viral load and pulmonary functions can contribute to identifying potential risk factors for long COVID and developing preventive measures to mitigate the long-term impact on lung health.</AbstractText><AbstractText Label="CLINICAL TRIAL NUMBER" NlmCategory="BACKGROUND">Not applicable.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Uzair</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Dow University of Health Sciences, Karachi, Pakistan. uzair.abbas@duhs.edu.pk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aga Khan University hospital, Karachi, Pakistan. uzair.abbas@duhs.edu.pk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Ishfaque</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sindh Infectious Diseases Hospital and Research Center, DUHS, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afshan</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sindh Infectious Diseases Hospital and Research Center, DUHS, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jogezai</LastName><ForeName>Zulfiqar Haider</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Aga Khan University hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Parshad</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Liaquat University of Medical and Health Sciences, Thatta campus, Thatta, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahsan</LastName><ForeName>Aiman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehan</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Niaz</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faheem</LastName><ForeName>Samar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dow University of Health Sciences, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baloch</LastName><ForeName>Israr Ahmed</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Lehigh valley Hospital Cedar Crest, Allentown Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yameen</LastName><ForeName>Maliha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aga Khan University hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="Y">Spirometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="Y">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Middle-aged population</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Spirometry</Keyword><Keyword MajorTopicYN="N">Viral load</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39354396</ArticleId><ArticleId IdType="pmc">PMC11446109</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09959-w</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09959-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization COVID-19 report. 2023. https://covid19.who.int/</Citation></Reference><Reference><Citation>Rando R HM, MacLean AL, Lee AJ, Lordan, Ray S, Bansal V, et al. Pathogenesis, symptomatology, and transmission of SARS-CoV-2 through analysis of viral genomics and structure. MSystems. 2021;6:msystems101128&#x2013;00095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8547481</ArticleId><ArticleId IdType="pubmed">34698547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020;94:44&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102543</ArticleId><ArticleId IdType="pubmed">32171952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanjari M, Late S, Sharma R, Munjewar P. Long-term pulmonary and extra-pulmonary consequences of COVID-19: a comprehensive review of current evidence and future perspectives. Narra J. 2023;3:e156&#x2013;e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10919748</ArticleId><ArticleId IdType="pubmed">38454970</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Heerden J. The impact of SARS-CoV-2 on respiratory function. Stellenbosch: Stellenbosch University; 2023.</Citation></Reference><Reference><Citation>De Juana C, Herrera S, Ponce S, Calvache S, Dahmazi L, Vitale R, et al. Health-related quality of life and radiological and functional lung changes of patients with COVID-19 pneumonia 3 and 10 months after discharge. BMC Pulm Med. 2023;23:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10303856</ArticleId><ArticleId IdType="pubmed">37370050</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbar AS, Mohammed RN, Ibrahim NK. Impact of COVID-19 infection on pulmonary function tests in patients 6&#x2013;8 weeks after recovery. Int Med J. 2021;28:5341&#x2013;51.</Citation></Reference><Reference><Citation>Hastie E, Amogan H, Looney D, Mehta SR. Association between SARS-CoV-2 viral load and patient symptoms and clinical outcomes using droplet digital PCR. Viruses. 2023;15:446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9961727</ArticleId><ArticleId IdType="pubmed">36851660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence R, Singh RB, Prakash AK. Pulmonary function abnormality in patients recovered from Covid 19 pneumonia, in a tertiary care hospital in India. Lung India. 2023;40:248&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10298824</ArticleId><ArticleId IdType="pubmed">37148023</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi RT, Lynch JB, Del Rio C. Mild or moderate Covid-19. N Engl J Med. 2020;383:1757&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022, 60.</Citation><ArticleIdList><ArticleId IdType="pubmed">34949706</ArticleId></ArticleIdList></Reference><Reference><Citation>Birman D. Investigation of the effects of Covid-19 on different organs of the body. Eurasian J Chem Med Petroleum Res. 2023;2:24&#x2013;36.</Citation></Reference><Reference><Citation>Toufen C, P&#xea;go-Fernandes PM. COVID-19: long-term respiratory consequences. SciELO Brasil; 2021. pp. 421&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9632533</ArticleId><ArticleId IdType="pubmed">34287513</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil S, Narkar S, Dahiphale J, Raka V, Choudhari S, Gondhali G. Long COVID symptoms, pathophysiology and possible mechanisms: still, we are learning! World J Adv Pharm Med Res. 2023;4:053&#x2013;65.</Citation></Reference><Reference><Citation>Buonsenso D, Piazza M, Boner AL, Bellanti JA, editors. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy and Asthma Proceedings; 2022: OceanSide Publications.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="pubmed">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutey-Magni PF, Williams H, Jhass A, Rait G, Lorencatto F, Hemingway H, et al. COVID-19 infection and attributable mortality in UK care homes: cohort study using active surveillance and electronic records (March&#x2013;June 2020). Age Ageing. 2021;50:1019&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989651</ArticleId><ArticleId IdType="pubmed">33710281</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respiratory Med. 2022;10:863&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health&#x2013;Europe 2021, 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021, 38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken IR, Saginc G, He L, Huseynov A, Daniels A, Fletcher S, et al. Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation. 2021;143:865&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7899720</ArticleId><ArticleId IdType="pubmed">33405941</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa Y, Khalil MM, Hegazy SN, Daif MS. The outcome of pulmonary function tests and high-resolution computed tomography of chest in post-coronavirus disease 2019-confirmed cases after 3 months of recovery. Egypt J Chest Dis Tuberculosis. 2023;72:46&#x2013;57.</Citation></Reference><Reference><Citation>Cherrez-Ojeda I, Sanchez-Angarita E, Vanegas E, Baja&#xf1;a MJF, Robles-Velasco K, Osorio MF, et al. Pulmonary evaluation of post-COVID-19 patients: an Ecuadorian experience. J Community Hosp Intern Med Perspect. 2022;12:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9195060</ArticleId><ArticleId IdType="pubmed">35712691</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro AO, Cervantes-Bojalil J, Quevedo OJC, Mart&#xed;nez AA, Hern&#xe1;ndez-Jim&#xe9;nez CA, &#xc1;lvarez EP, et al. Decreased quality of life and spirometric alterations even after mild-moderate COVID-19. Respir Med. 2021;181:106391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8044599</ArticleId><ArticleId IdType="pubmed">33865161</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes-Telles A, Figueroa-Hurtado E, Ortiz-Farias DL, Zavorsky GS. Clinical predictors of lung function in patients recovering from mild COVID-19. BMC Pulm Med. 2022;22:294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9339191</ArticleId><ArticleId IdType="pubmed">35909118</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui Z, Dai X, Lu Q, Zhang Y, Huang M, Li S, et al. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection. Signal Transduct Target Therapy. 2021;6:181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107204</ArticleId><ArticleId IdType="pubmed">33972497</ArticleId></ArticleIdList></Reference><Reference><Citation>Zsichla L, M&#xfc;ller V. Risk factors of severe COVID-19: a review of host, viral and environmental factors. Viruses. 2023;15:175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9863423</ArticleId><ArticleId IdType="pubmed">36680215</ArticleId></ArticleIdList></Reference><Reference><Citation>Ra SH, Lim JS, Kim G-u, Kim MJ, Jung J, Kim S-H. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax. 2021;76:61&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32963115</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11:5493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Francistiov&#xe1; L, Klepe A, Curley G, Gulya K, Dinny&#xe9;s A, Filkor K. Cellular and molecular effects of SARS-CoV-2 linking lung infection to the brain. Front Immunol. 2021;12:730088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414801</ArticleId><ArticleId IdType="pubmed">34484241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>